Loading
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Dec 2019 for Novelion Therapeutics Inc., €2,456. Read the official filing
Filing timeline
BuySaleStonepine Capital Management, LLC
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
Stonepine Capital Management, LLC: trading record in brief
Stonepine Capital Management, LLC discloses dealings in Novelion Therapeutics Inc. to SEDI. Over a trading history stretching from 23 September 2019 to 12 December 2019, the count stands at 6 filings.
On the market, this insider has only ever bought: 5 purchases, €93k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €2,456. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 13 December 2019: an open-market purchase of €2,456, in Novelion Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stonepine Capital Management, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
5,202 shares@ CA$0.69162.6% of flowCommon SharesTSXSEDI:3465133
Canonical exit: 9 Mar 2020 (T+90)
40 shares@ CA$0.690.0% of flowCommon SharesTSXSEDI:3465134
Canonical exit: 10 Mar 2020 (T+90)
1,000 shares@ CA$0.700.5% of flowCommon SharesTSXSEDI:3465135
Canonical exit: 11 Mar 2020 (T+90)
89,845 shares@ CA$0.746149.1% of flowCommon SharesTSXSEDI:3455551
Canonical exit: 20 Feb 2020 (T+90)
100,000 shares@ CA$0.64947.7% of flowCommon SharesTSXSEDI:3439463
Canonical exit: 9 Jan 2020 (T+90)
Common SharesTSXSEDI:3439462
6 of 6 declarations
